MAI Journal: A New Zealand Journal of Indigenous Scholarship
September 1, 2023
Rawiri Waretini-Karena, Julia Wikeepa
This article begins by identifying and defining a range of debilitating disorders— trauma, posttraumatic stress disorder (PTSD) and generalised anxiety—and their symptoms before presenting a statistical analysis to give scope to the impact of the disorders. The article then explores the science behind breathing and breathwork as a valuable antidote to these disorders. The whakapapa of the...
Journal of Psychoactive Drugs
September 1, 2023
V. Tsang, Dragos C Razagan, P. Kryskow et al.
10 citations
ABSTRACT The prevalence of depression, anxiety, and post-traumatic stress disorder (PTSD) has increased among healthcare providers, while the effectiveness of conventional treatments remains limited. Ketamine-assisted therapy offers a promising alternative; however, few have integrated ketamine with a group-based therapeutic modality. We report a retrospective, secondary analysis of a 12-week...
Safety and health at work
September 1, 2023
Quentin Durand-Moreau, Tanya Jackson, Danika Deibert et al.
The effectiveness of mindfulness techniques in addressing mental health conditions in workers is uncertain. However, it could represent a therapeutic tool for workers presenting with such conditions. Our objective was to assess the effects of mindfulness-based practices for workers diagnosed with mental health conditions. We conducted a systematic review of randomized controlled trials....
Journal of Substance Use and Addiction Treatment
September 1, 2023
Therese K Killeen, Nathaniel L Baker, Lori L. Davis et al.
3 citations
Complementary integrative medicine, such as mindfulness-based interventions, (MBI) have demonstrated efficacy in the treatment of depression, anxiety, substance use disorders (SUDs), and pain. Mindfulness-based relapse prevention (MBRP) is an aftercare intervention targeting SUD relapse that integrates cognitive-behavioral relapse prevention and mindfulness meditation practices, raising...
International Journal of Older People Nursing
September 1, 2023
Ka-Yan Ko, Zoe Ching Man Kwok, Helen Yue-Lai Chan
37 citations
To synthesise and critically appraise the quality of existing evidence about the effects of yoga on physical and psychological outcomes among older adults. A systematic review and meta-analysis. Participants aged 60 and above. Nine English and two Chinese electronic bibliographic databases, including MEDLINE OvidSP, PsycINFO, AMED, EMBASE, Global Health, PubMed, Scopus, CINAHL, Cochrane...
Psychedelic Medicine
September 1, 2023
Harpreet Kaur, Sedat Karabulut, James W Gauld et al.
10 citations
Autism spectrum disorder (ASD) encompasses a range of neurodevelopmental syndromes diagnostically characterized by deficits in social communication and social interaction and repetitive, inflexible patterns of behaviors, interests, and thoughts. ASD affects people worldwide, irrespective of race, ethnicity, or socio-economic status, with debilitating effects on employment and interpersonal...
Molecular Psychiatry
September 1, 2023
Alaina M Jaster, Javier González-Maeso
50 citations
Psychedelics, also known as classical hallucinogens, have been investigated for decades due to their potential therapeutic effects in the treatment of neuropsychiatric and substance use disorders. The results from clinical trials have shown promise for the use of psychedelics to alleviate symptoms of depression and anxiety, as well as to promote substantial decreases in the use of nicotine and...
Journal of Psychiatric Practice
September 1, 2023
Amir Garakani, Jeanne L Alexander, Calvin R Sumner et al.
6 citations
There has been a burgeoning interest in psychedelics among the public, state legislatures, psychiatrists and other clinical providers, and within the research community. Increasing numbers of studies evaluating psychedelics for depression, anxiety, posttraumatic stress disorder, and substance use disorders have been conducted or are underway. While discussing psychedelics in general, the focus...
Molecular Psychiatry
September 1, 2023
Kat F. Kiilerich, Joe Lorenz, Malthe B. Scharff et al.
48 citations
Psilocybin (a classic serotonergic psychedelic drug) has received appraisal for use in psychedelic-assisted therapy of several psychiatric disorders. A less explored topic concerns the use of repeated low doses of psychedelics, at a dose that is well below the psychedelic dose used in psychedelic-assisted therapy and often referred to as microdosing. Psilocybin microdose users frequently report...
Cureus
September 1, 2023
Nm Mahmudul Alam Bhuiya, Robin J Jacobs, Karina Wang et al.
3 citations
Background Psilocybin has been studied for its potential therapeutic benefits, particularly for the treatment of psychiatric disorders such as anxiety, depression, and obsessive-compulsive disorder. While more research is needed as psilocybin-assisted therapy becomes more prevalent, future pharmacists will probably be involved at some level. At present, pharmacists receive minimal training on...